Opus Genetics News and Activities

Opus Genetics is a company listed under the stock ticker IRD (US).

View the org chart displaying its 19 main executives

Most searched biographies at Opus Genetics

• George Magrath, Chief Executive Officer
• Sean Ainsworth, Director
• Susan Benton, Director

Popular executive movements at Opus Genetics

• Peter Catalano has joined the company as Vice President of Accounting  (posted on November 28 2025).

Create your alert
to follow the executive moves at Opus Genetics.

Opus Genetics has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Opus Genetics

Social media about Opus Genetics

• Opus Genetics on Wikipedia, Google News & Yahoo Finance
• Opus Genetics on LinkedIn, X (Twitter) & YouTube